Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Pulsatile GnRH Therapy on Cognition in Down Syndrome: Randomized Placebo Control Study

NCT04390646 is registered in ClinicalTrials.gov with Nelly Pitteloud as lead sponsor.

NCT NCT04390646
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04390646 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Pulsatile GnRH Therapy on Cognition in Down Syndrome: Randomized Placebo Control Study
Lead sponsor
Nelly Pitteloud
Phase
Phase 2/3
Overall status
Recruiting
Start date
August 27, 2020
Completion date
December 31, 2028
Enrollment
56 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, early onset, cognitive decline, down syndrome, olfaction disorders